The Impact of Race, Ethnicity and Insurance Status on Surgery Rates for Benign Prostatic Hyperplasia

Antoine, Samuel; Carmichael, Heather; Lloyd, Granville L.

doi:10.1016/j.urology.2021.05.092

Cited by 2 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These findings are consistent with those of recent studies evaluating treatment disparities in BPH. Antoine et al identified BPH treatment disparities by race in a singlecenter review after adjusting for age, insurance status, major comorbidities, and type of pharmacotherapy [9]. Furthermore, in an analysis of the California medical database, Gill et al found that Black patients were less likely than White patients to be treated with medications or surgery in the first year following their BPH diagnosis [8].…”

Section: Discussionmentioning

confidence: 99%

“…It is important all treatment options are available to all BPH patients. Recent studies have identified racial and socioeconomic disparities in the treatment of BPH, with Black, Indigenous, and People of Color (BIPOC) patients shown to be undertreated relative to White patients [8][9][10][11][12]. Furthermore, where patients access care, including the service location for BPH surgeries, impacts treatment options.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Is Race Associated with the Surgical Treatment for Benign Prostatic Hyperplasia? An Analysis of 30,000 Medicare Lives

Narang

Rojanasarot

Cutone

et al. 2023

J. Racial and Ethnic Health Disparities

View full text Add to dashboard Cite

Backgrounds With an increased prevalence and burden of benign prostatic hyperplasia (BPH), effective and equitable treatment is a priority. Limited data exist evaluating treatment disparities for patients with BPH by race. This study examined the association between race and BPH surgical treatment rates among Medicare beneficiaries. Methods Medicare claims data were used to identify men newly diagnosed with BPH from January 1, 2010 through December 31, 2018. Patients were followed until their first BPH surgery, a diagnosis of prostate/bladder cancer, termination of Medicare enrollment, death, or end of study. Cox proportional hazards regression compared the likelihood of BPH surgery between men of different races (White vs. Black, Indigenous, and People of Color (BIPOC)), controlling for patients’ geographical region, Charlson comorbidity score, and baseline comorbidities. Results The study included 31,699 patients (13.7% BIPOC). BIPOC men had significantly lower BPH surgery rates (9.5% BIPOC vs. 13.4% White; p=0.02). BIPOC race was associated with a 19% lower likelihood of receiving BPH surgery than White race (HR, 0.81; 95% CI 0.70, 0.94). Transurethral resection of the prostate was the most common surgery for both groups (49.4% Whites vs. 56.8% BIPOC; p=0.052). A higher proportion of BIPOC men underwent procedures in inpatient settings compared to White men (18.2% vs. 9.8%; p<0.001). Conclusions Among a cohort of Medicare beneficiaries with BPH, there were notable treatment disparities by race. BIPOC men had lower rates of surgery than White men and were more likely to undergo procedures in the inpatient setting. Improving patient access to outpatient BPH surgical procedures may help address treatment disparities.

show abstract

Section: Discussionmentioning

confidence: 99%